IBDEI0PX ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12737,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,12738,0)
 ;;=191.9^^75^791^7
 ;;^UTILITY(U,$J,358.3,12738,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12738,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,12738,1,2,0)
 ;;=2^BRAIN CANCER
 ;;^UTILITY(U,$J,358.3,12738,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,12739,0)
 ;;=171.9^^75^791^52
 ;;^UTILITY(U,$J,358.3,12739,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12739,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,12739,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,12739,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,12740,0)
 ;;=150.9^^75^791^16
 ;;^UTILITY(U,$J,358.3,12740,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12740,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,12740,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,12740,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,12741,0)
 ;;=153.9^^75^791^15
 ;;^UTILITY(U,$J,358.3,12741,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12741,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,12741,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,12741,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,12742,0)
 ;;=152.9^^75^791^57
 ;;^UTILITY(U,$J,358.3,12742,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12742,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,12742,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,12742,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,12743,0)
 ;;=193.^^75^791^62
 ;;^UTILITY(U,$J,358.3,12743,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12743,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,12743,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,12743,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,12744,0)
 ;;=284.9^^75^791^3
 ;;^UTILITY(U,$J,358.3,12744,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12744,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,12744,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,12744,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,12745,0)
 ;;=170.9^^75^791^6
 ;;^UTILITY(U,$J,358.3,12745,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12745,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,12745,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,12745,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,12746,0)
 ;;=175.9^^75^791^9
 ;;^UTILITY(U,$J,358.3,12746,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12746,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,12746,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,12746,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,12747,0)
 ;;=209.10^^75^791^10
 ;;^UTILITY(U,$J,358.3,12747,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12747,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,12747,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,12747,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,12748,0)
 ;;=209.29^^75^791^11
 ;;^UTILITY(U,$J,358.3,12748,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12748,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,12748,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,12748,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,12749,0)
 ;;=209.00^^75^791^12
 ;;^UTILITY(U,$J,358.3,12749,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12749,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,12749,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,12749,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,12750,0)
 ;;=156.9^^75^791^13
 ;;^UTILITY(U,$J,358.3,12750,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12750,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,12750,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,12750,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,12751,0)
 ;;=286.9^^75^791^14
 ;;^UTILITY(U,$J,358.3,12751,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12751,1,1,0)
 ;;=1^286.9
